March 18, 2024
A landmark study, led by Yen-Yu Ian Shih, PhD, professor of neurology and associate director of UNC’s Biomedical Research Imaging Center, could alter how researchers interpret results from functional magnetic resonance imaging.
March 15, 2024
New research by the lab of Jessica Thaxton, PhD, MsCR, in the Department of Cell Biology and Physiology at the UNC School of Medicine and colleagues in the Immunotherapy Group at the UNC Lineberger Comprehensive Cancer Center, has unveiled new clues behind T-cell metabolism that could enhance immunotherapies that rely on T cells to fight cancer.
March 6, 2024
In this new Vital Signs series, we feature graduate student Max Hockenberry, who performs research in the labs of Wes Legant, PhD, and Jim Bear, PhD. Hockenberry is developing new microscopy methods so researchers can measure the mechanisms cells use to maneuver through tight spaces in the body.
February 29, 2024
Klaus Hahn, PhD, the Ronald G. Thurman Distinguished Professor of Pharmacology at the UNC School of Medicine, will co-lead this Chan Zuckerberg Initiative project with colleagues at Duke University and North Carolina State University.
February 29, 2024
In this new Vital Signs series, we feature graduate student Elizabeth Minor in the Ehre lab. Inspired by an immunology and cancer immunotherapy class during her time at the University of Virginia, Minor now studies viral challenges like SARS-CoV-2 and cystic fibrosis at the prestigious Marsico Lung Institute/UNC Cystic Fibrosis Center.
February 28, 2024
Under the direction of assistant professor of radiology Li-Ming Hsu, the research demonstrates how long-term cocaine use affects brain functions, making recovery and stifling cravings more difficult.
February 27, 2024
The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.
February 26, 2024
A research study named Early Check has screened 1,000 newborns after birth in an effort to help identify rare conditions early, provide treatment, give parents educational information, and connect families with specialists throughout the state of North Carolina.
February 13, 2024
In this new Vital Signs series, we feature graduate student Autumn Grace Hullings in the Gordon-Larsen lab. Inspired by the emerging field of precision nutrition, Hullings would like to improve dietary guidelines to prevent or reduce cardiometabolic disease.
February 13, 2024
Cynthia L. Gay, MD, MPH, associate professor of infectious diseases, and David Margolis, MD, the Sarah Kenan Distinguished Professor of Medicine, Microbiology & Immunology, and Epidemiology in the UNC School of Medicine, published results of a clinical trial showing that vorinostat and immunotherapy may modestly shrink the latent HIV reservoir.
February 9, 2024
In an effort five years in the making, UNC School of Medicine cell biologist Sarah Cohen, PhD, and Rockefeller University’s Ian Windham, PhD, describe the interplay between fats and proteins in brain cells and how their dysfunction contributes to the development of late-onset Alzheimer’s disease.
February 8, 2024
The UNC School of Medicine is on pace to become one of the few sites in the United States to incorporate intestinal ultrasound as an imaging technique for managing Inflammatory Bowel Disease.